SUBSCRIBE
SUBSCRIBE

Australia

Genetown
185 Effective Verbs For Your Resume
August 16, 2017
 · 
1 min read
Biotech Bay
The 4 Types Of Collaborations That Could Create Jobs For Scientists
August 16, 2017
 · 
1 min read
Men Who Eat Fruits And Veggies May Be More Attractive To Women, Macquarie University Reveals
August 16, 2017
 · 
1 min read
Antares Pharma Implodes After FDA Responds to Its Xyosted NDA
Business
Novogen Restructures, Board to Take Pay Cuts
August 14, 2017
 · 
2 min read
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations
Business
Immuron CEO Thomas Liquard Resigns
August 3, 2017
 · 
3 min read
Genetown
How Long Will A Successful Career Change To Pharma Manufacturing Take?
July 26, 2017
 · 
1 min read
Genetown
This Cover Letter Checklist Can Help You Show Off Your Personality The Right Way
This cover letter checklist can help you write impressive cover letters that describe your personality in the perfect way to employers. Follow the checklist and up your game.
July 26, 2017
 · 
1 min read
Genetown
The Leadership Skill Everybody Needs-And 90% Of Managers Lack
July 26, 2017
 · 
1 min read
Genetown
Why Scientists Should Ditch The Postdoc And Just Jump Into The Industry
July 26, 2017
 · 
1 min read
Genetown
How Scientists Can Negotiate Higher Salary Contracts
July 26, 2017
 · 
1 min read
Load More
PRESS RELEASES
Opthea to Present at the FLORetina 2023 Congress
December 1, 2023
 · 
2 min read
Drug Development
Registrational Phase III CLARIFY trial in prostate cancer commences
November 30, 2023
 · 
5 min read
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
November 30, 2023
 · 
8 min read
Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS
November 29, 2023
 · 
6 min read
Drug Development
Clarity’s theranostic prostate cancer trial progresses at the highest dose level cohort
November 29, 2023
 · 
7 min read
Biotech Beach
US FDA Grants the BiVACOR Total Artificial Heart IDE Approval for First-in-Human Early Feasibility Study
November 29, 2023
 · 
4 min read
Drug Development
SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes
November 29, 2023
 · 
7 min read
Kazia Announces Non-binding Letter of Intent for the Proposed Granting of Rights to Develop and Commercialize Paxalisib Outside of Oncology
November 29, 2023
 · 
4 min read
Recce Pharmaceuticals Granted New Patent in Canada for RECCE® Anti-Infectives
November 27, 2023
 · 
4 min read
Biotech Bay
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
November 27, 2023
 · 
7 min read
Pharm Country
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
November 26, 2023
 · 
3 min read
Drug Development
Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa
November 26, 2023
 · 
6 min read
Drug Development
Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
November 22, 2023
 · 
3 min read
Kazia Provides Overview of Paxalisib Related Presentations From the Society of Neuro-Oncology 2023 Annual Meeting
November 21, 2023
 · 
7 min read
Drug Development
Sapient Therapeutics Announce Positive Results From Phase 1 Part A Trial for Its Solid Dose Prescription CBD
November 21, 2023
 · 
1 min read
BioForest
Data Presentation at Association for Molecular Pathology 2023 Validates Performance of SeptiCyte® RAPID in Immunocompromised Patients and Patients on Immunosuppressive Therapy
November 17, 2023
 · 
4 min read
Biotech Bay
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
November 16, 2023
 · 
5 min read
Drug Development
Certa Therapeutics presents positive data from a Phase 2 clinical study highlighting the potential benefit of FT011 as a novel treatment for scleroderma
November 15, 2023
 · 
8 min read
KAZIA ANNOUNCES THE RELEASE OF PNOC022 CLINICAL STUDY ABSTRACT HIGHLIGHTING PAXALISIB IN DIFFUSE MIDLINE GLIOMA PATIENTS AHEAD OF THE SOCIETY OF NEURO-ONCOLOGY 2023 ANNUAL MEETING
November 15, 2023
 · 
6 min read
Immuron CEO Steven Lydeamore Investor Webinar Presentation
November 13, 2023
 · 
1 min read
Load More